235 related articles for article (PubMed ID: 27926911)
1. First-Rank Symptoms in Methamphetamine Psychosis and Schizophrenia.
Shelly J; Uhlmann A; Sinclair H; Howells FM; Sibeko G; Wilson D; Stein DJ; Temmingh H
Psychopathology; 2016; 49(6):429-435. PubMed ID: 27926911
[TBL] [Abstract][Full Text] [Related]
2. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
[TBL] [Abstract][Full Text] [Related]
3. Differences in Clinical Features of Methamphetamine Users with Persistent Psychosis and Patients with Schizophrenia.
Wang LJ; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Chen CK
Psychopathology; 2016; 49(2):108-15. PubMed ID: 27071042
[TBL] [Abstract][Full Text] [Related]
4. A two-factor structure of first rank symptoms in patients with a psychotic disorder.
Heering HD; van Haren NE; Derks EM;
Schizophr Res; 2013 Jul; 147(2-3):269-74. PubMed ID: 23732016
[TBL] [Abstract][Full Text] [Related]
5. Does change in definition of psychotic symptoms in diagnosis of schizophrenia in DSM-5 affect caseness?
Tandon R; Bruijnzeel D; Rankupalli B
Asian J Psychiatr; 2013 Aug; 6(4):330-2. PubMed ID: 23810142
[TBL] [Abstract][Full Text] [Related]
6. Schneider's first-rank symptoms have neither diagnostic value for schizophrenia nor higher clinical validity than other delusions and hallucinations in psychotic disorders.
Peralta V; Cuesta MJ
Psychol Med; 2023 Apr; 53(6):2708-2711. PubMed ID: 32943125
[TBL] [Abstract][Full Text] [Related]
7. Shall we really say goodbye to first rank symptoms?
Heinz A; Voss M; Lawrie SM; Mishara A; Bauer M; Gallinat J; Juckel G; Lang U; Rapp M; Falkai P; Strik W; Krystal J; Abi-Dargham A; Galderisi S
Eur Psychiatry; 2016 Sep; 37():8-13. PubMed ID: 27429167
[TBL] [Abstract][Full Text] [Related]
8. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
[No Abstract] [Full Text] [Related]
9. Psychotic symptoms in methamphetamine psychotic in-patients.
Srisurapanont M; Ali R; Marsden J; Sunga A; Wada K; Monteiro M
Int J Neuropsychopharmacol; 2003 Dec; 6(4):347-52. PubMed ID: 14604449
[TBL] [Abstract][Full Text] [Related]
10. A latent class analysis of psychiatric symptom profiles associated with past-month methamphetamine use.
Voce A; Burns R; Castle D; Calabria B; McKetin R
Psychiatry Res; 2021 Apr; 298():113760. PubMed ID: 33548691
[TBL] [Abstract][Full Text] [Related]
11. Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.
Mahoney JJ; Hawkins RY; De La Garza R; Kalechstein AD; Newton TF
Gend Med; 2010 Oct; 7(5):414-21. PubMed ID: 21056868
[TBL] [Abstract][Full Text] [Related]
12. Bizarre delusions and first-rank symptoms in a first-admission sample: a preliminary analysis of prevalence and correlates.
Tanenberg-Karant M; Fennig S; Ram R; Krishna J; Jandorf L; Bromet EJ
Compr Psychiatry; 1995; 36(6):428-34. PubMed ID: 8565447
[TBL] [Abstract][Full Text] [Related]
13. A major flaw in the diagnosis of schizophrenia: what happened to the Schneider's first rank symptoms.
Moscarelli M
Psychol Med; 2020 Jul; 50(9):1409-1417. PubMed ID: 32524921
[TBL] [Abstract][Full Text] [Related]
14. 'Are these my thoughts?': A 20-year prospective study of thought insertion, thought withdrawal, thought broadcasting, and their relationship to auditory verbal hallucinations.
López-Silva P; Harrow M; Jobe TH; Tufano M; Harrow H; Rosen C
Schizophr Res; 2024 Mar; 265():46-57. PubMed ID: 35945121
[TBL] [Abstract][Full Text] [Related]
15. Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients.
Zarrabi H; Khalkhali M; Hamidi A; Ahmadi R; Zavarmousavi M
BMC Psychiatry; 2016 Feb; 16():44. PubMed ID: 26911516
[TBL] [Abstract][Full Text] [Related]
16. Typologies of positive psychotic symptoms in methamphetamine dependence.
Bousman CA; McKetin R; Burns R; Woods SP; Morgan EE; Atkinson JH; Everall IP; Grant I;
Am J Addict; 2015 Mar; 24(2):94-97. PubMed ID: 25864598
[TBL] [Abstract][Full Text] [Related]
17. [The clinical course of chronic methamphetamine psychoses].
Fujimori H; Nakatani Y; Sakaguchi M
Fortschr Neurol Psychiatr; 1989 Sep; 57(9):383-94. PubMed ID: 2793033
[TBL] [Abstract][Full Text] [Related]
18. Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia.
DeRosse P; Hodgkinson CA; Lencz T; Burdick KE; Kane JM; Goldman D; Malhotra AK
Biol Psychiatry; 2007 May; 61(10):1208-10. PubMed ID: 17054920
[TBL] [Abstract][Full Text] [Related]
19. The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
Voce A; McKetin R; Burns R; Castle D; Calabria B
Psychiatry Res; 2018 Jul; 265():19-24. PubMed ID: 29680513
[TBL] [Abstract][Full Text] [Related]
20. The role of age in the development of Schneiderian symptoms in patients with a first psychotic episode.
González-Pinto A; van Os J; Peralta V; Pérez de Heredia JL; Mosquera F; Aldama A; González C; Gutiérrez M; Micó JA
Acta Psychiatr Scand; 2004 Apr; 109(4):264-8. PubMed ID: 15008799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
